Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Orally Active Peptides: Is There a Magic Bullet?
Räder AFB, Weinmüller M, Reichart F, Schumacher-Klinger A, Merzbach S, Gilon C, Hoffman A, Kessler H. Räder AFB, et al. Among authors: schumacher klinger a. Angew Chem Int Ed Engl. 2018 Oct 26;57(44):14414-14438. doi: 10.1002/anie.201807298. Epub 2018 Oct 3. Angew Chem Int Ed Engl. 2018. PMID: 30144240 Review.
Enhancing Oral Bioavailability of Cyclic RGD Hexa-peptides by the Lipophilic Prodrug Charge Masking Approach: Redirection of Peptide Intestinal Permeability from a Paracellular to Transcellular Pathway.
Schumacher-Klinger A, Fanous J, Merzbach S, Weinmüller M, Reichart F, Räder AFB, Gitlin-Domagalska A, Gilon C, Kessler H, Hoffman A. Schumacher-Klinger A, et al. Mol Pharm. 2018 Aug 6;15(8):3468-3477. doi: 10.1021/acs.molpharmaceut.8b00466. Epub 2018 Jul 25. Mol Pharm. 2018. PMID: 29976060
Cyclizing Painkillers: Development of Backbone-Cyclic TAPS Analogs.
Talhami A, Swed A, Hess S, Ovadia O, Greenberg S, Schumacher-Klinger A, Rosenthal D, Shalev DE, Hurevich M, Lazarovici P, Hoffman A, Gilon C. Talhami A, et al. Among authors: schumacher klinger a. Front Chem. 2020 Nov 12;8:532577. doi: 10.3389/fchem.2020.532577. eCollection 2020. Front Chem. 2020. PMID: 33282822 Free PMC article.
Synthesis and Pharmacological Characterization of Visabron, a Backbone Cyclic Peptide Dual Antagonist of α4β1 (VLA-4)/α9β1 Integrin for Therapy of Multiple Sclerosis.
Gilon C, Klazas M, Lahiani A, Schumacher-Klinger A, Merzbach S, Naoum JN, Ovadia H, Rubin L, Cornell-Kennon S, Schaefer EM, Katzhendler J, Marcinkiewicz C, Hoffman A, Lazarovici P. Gilon C, et al. Among authors: schumacher klinger a. JACS Au. 2021 Nov 24;1(12):2361-2376. doi: 10.1021/jacsau.1c00496. eCollection 2021 Dec 27. JACS Au. 2021. PMID: 34977904 Free PMC article.